Skip to main content
Signal8

Ory Daniel Scott

SEC insider (Form 3/4/5 filer). CIK 0002149618. EVP, Chief Medical Officer at Editas Medicine, Inc. (EDIT). 1 reported Form 4/5 transaction since Sep 2024; latest on Sep 8, 2026. Located in CAMBRIDGE, MA.

Companies Ory Daniel Scott has filed insider reports for

  • Editas Medicine, Inc. (EDIT): Officer, EVP, Chief Medical Officer
Ory Daniel Scott profile photo

Ory Daniel Scott

CIK: 0002149618

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Editas Medicine, Inc. logo
EDIT

Editas Medicine, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Editas Medicine, Inc. logo
    EDIT

    Editas Medicine, Inc.

    Sep 8, 2026
    Award

    Stock Option (right to buy)

    Direct
    950K shares-

1-1 of 1